In patients with CHH, varicella vaccine was given to patients with CD4 + T cells as low as 0.2 × 109/L, with no serious adverse events reported and comparable cellular response to healthy controls [6]; however, humoral responses were decreased compared to controls. This evidence concerns the gene CD4 and cartilage-hair hypoplasia.